Robert Stirrups. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useBortezomib/therapeutic useConfidence IntervalsDisease-Free SurvivalFemaleHospitals, UniversityHumansMaleMelphalan/therapeutic useMultiple Myeloma/diagnosisMultiple Myeloma/drug therapyMultiple Myeloma/mortalityPrednisone/therapeutic usePrognosisProportional Hazards ModelsSpainSurvival Analysis
Substances: See more » Antibodies, MonoclonaldaratumumabBortezomibMelphalanPrednisone
Year: 2017 PMID: 29276025 DOI: 10.1016/S1470-2045(17)30951-8
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316